Renal Adjuvant MultiPle Arm Randomised Trial

(CLOSED)

An International investigator-led phase III multi-arm multi-stage multi-centre randomised controlled platform trial of adjuvant therapy in patients with resected primary renal cell carcinoma (RCC) at high or intermediate risk of relapse.